Arch. Endocrinol. Metab. 2022;66(1):132-133
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
DOI: 10.20945/2359-3997000000453
DEAR EDITOR,
We have read with interest the article published by Martins JRM, which that tells us about the side effects of anti-thyroid medications in hyperthyroidism and the possibility of definitive treatment once this has occurred (). The SARS-CoV-2 virus pandemic has displaced much of the health system’s resources, compromising care for other diseases, including hyperthyroidism. Various documents have been presented with the intention of outlining its treatment during the pandemic, focusing it on the use of oral antithyroid therapy due to the impossibility of performing thyroidectomies or administration radioiodine (131I). However, the course to follow in any adverse effect of these has not been clearly indicated, which is worrying, given the lack of alternatives in this context.
[…]